Moderna's Shares Could Take Off if These 2 Things Happen
(NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021. That was as the biotech company brought its coronavirus vaccine from the lab to market and generated billions of dollars in earnings. Investors liked that, and it clearly showed in the stock performance.
But Moderna stock lost ground once investors started to think about the future and what sales might look like in a post-pandemic world. After all, the vaccine is Moderna's only product right now, and demand for it has declined. And, in spite of Moderna's progress on late-stage programs and encouraging future revenue forecasts, the shares have failed to take off.
Two particular factors, though, could turn things around for the company. Let's check out these potential events that might boost the stock in the coming months.
Source Fool.com
Moderna Inc. Aktie
Starkes Buy-Sentiment bei Moderna Inc. mit 21 Buy- gegenüber 2 Sell-Einschätzungen.
Das Kursziel von 129 € für Moderna Inc. weist auf eine Steigerung von über 50% gegenüber dem aktuellen Kurs von 81.2 € hin.
